研究者詳細 - 安藤　雄一

論文 - 安藤　雄一

分割表示 111 件中 81 - 100 件目／全件表示 >>

Docetaxel, cisplatin and fluorouracil as neoadjuvant chemotherapy for esophageal cancer with prophylactic pegfilgrastim

Maeda, O; Koike, M; Fukaya, M; Miyata, K; Iwata, N; Nagino, M; Kodera, Y; Ando, Y

ANNALS OF ONCOLOGY 29 巻 2018年10月

Outpatient chemotherapy for patients with unresectable or metastatic bone sarcomas

Urakawa, H; Nishida, Y; Mitsuma, A; Maeda, O; Sugishita, M; Shimokata, T; Mizutani, T; Arai, E; Ikuta, K; Hamada, S; Ota, T; Ishiguro, N; Ando, Y

ANNALS OF ONCOLOGY 29 巻 2018年10月

Phase I study of spartalizumab (PDR001), an anti-PD1 mAb, in Japanese patients with advanced malignancies

Ando, Y; Doi, T; Mitsuma, A; Mizutani, T; Toyoda, M; Imamura, Y; Kiyota, N; Naito, Y; Matsubara, N; Ishihara, K; Tajima, T; Tokushige, K; Cameron, S; Minami, H

ANNALS OF ONCOLOGY 29 巻 2018年10月

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)

Nakayama, G; Mitsuma, A; Sunagawa, Y; Ishigure, K; Yokoyama, H; Matsui, T; Nakayama, H; Nakata, K; Ishiyama, A; Asada, T; Umeda, S; Ezaka, K; Hattori, N; Takami, H; Kobayashi, D; Tanaka, C; Kanda, M; Yamada, S; Koike, M; Fujiwara, M; Fujii, T; Murotani, K; Ando, Y; Kodera, Y

ONCOLOGIST 23 巻 ( 8 ) 頁： 919 - 927 2018年8月

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

Yamada, S; Fujii, T; Yokoyama, Y; Kawashima, H; Maeda, O; Suzuki, K; Okada, T; Ono, E; Yamaguchi, J; Takano, N; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Kodera, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY 81 巻 ( 5 ) 頁： 815 - 821 2018年5月

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study.

Kobayashi T, Iwama S, Yasuda Y, Okada N, Tsunekawa T, Onoue T, Takagi H, Hagiwara D, Ito Y, Morishita Y, Goto M, Suga H, Banno R, Yokota K, Hase T, Morise M, Hashimoto N, Ando M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H

Journal of the Endocrine Society 2 巻 ( 3 ) 頁： 241 - 251 2018年3月

Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial 査読有り

Tsukuura, H; Miyazaki, M; Morita, T; Sugishita, M; Kato, H; Murasaki, Y; Gyawali, B; Kubo, Y; Ando, M; Kondo, M; Yamada, K; Hasegawa, Y; Ando, Y

ONCOLOGIST 23 巻 ( 3 ) 頁： 367 - 374 2018年3月

Phase II trial of oral S-1 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard chemotherapies (CCOG-1105 study).

Ezaka, K; Nakayama, G; Yokoyama, H; Matsui, T; Umeda, S; Sunagawa, Y; Murotani, K; Ando, Y; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY 36 巻 ( 4 ) 2018年2月

Randomized phase II trial of CapOX plus bevacizumab versus CapIRI plus bevacizumab as first-line treatment in Japanese patients with metastatic colorectal cancer (CCOG-1201).

Sasahara, M; Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Ishiyama, A; Matsui, T; Nakayama, H; Kobayashi, D; Umeda, S; Sunagawa, Y; Murotani, K; Ando, Y; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY 36 巻 ( 4 ) 2018年2月

Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan 査読有り

Morita, S; Kikumori, T; Tsunoda, N; Inaishi, T; Adachi, Y; Ota, A; Shibata, M; Matsuoka, A; Nakanishi, K; Takeuchi, D; Mizutani, T; Shimokata, T; Hayashi, H; Maeda, O; Ando, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 23 巻 ( 1 ) 頁： 195 - 200 2018年2月

Guidelines for treatment of renal injury during cancer chemotherapy 2016

Horie, S; Oya, M; Nangaku, M; Yasuda, Y; Komatsu, Y; Yanagita, M; Kitagawa, Y; Kuwano, H; Nishiyama, H; Ishioka, C; Takaishi, H; Shimodaira, H; Mogi, A; Ando, Y; Matsumoto, K; Kadowaki, D; Muto, S

CLINICAL AND EXPERIMENTAL NEPHROLOGY 22 巻 ( 1 ) 頁： 210 - 244 2018年2月

Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancer 査読有り

Hayashi, N; Matsuoka, A; Goto, H; Gotoh, M; Kiyoi, H; Kodera, Y; Nagino, M; Nagashima, F; Ando, Y

JOURNAL OF GERIATRIC ONCOLOGY 9 巻 ( 1 ) 頁： 84 - 86 2018年1月

Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan

Maeda, O; Yokoyama, Y; Yamaguchi, J; Ota, A; Matsuoka, A; Morita, S; Inoue, M; Mizutani, T; Shimokata, T; Urakawa, H; Mitsuma, A; Nagino, M; Ando, Y

ANNALS OF ONCOLOGY 28 巻頁： 69 - 69 2017年11月

FDA Approval Summary: Sonidegib-Letter

Gyawali, B; Ando, Y

CLINICAL CANCER RESEARCH 23 巻 ( 19 ) 頁： 5993 - 5993 2017年10月

Gemcitabine plus cisplatin and S-1 for biliary tract cancer: a single institute analysis

Maeda, O; Shimokata, T; Mizutani, T; Inoue, M; Matsuoka, A; Ota, A; Mizuno, T; Ebata, T; Nagino, M; Ando, Y

ANNALS OF ONCOLOGY 28 巻頁： 50 - 50 2017年10月

Correlation and differences in Effect sizes between Progression Free Survival (PFS) and Overall Survival (OS) among PD-1 inhibitors

Gyawali, B; Shimokata, T; Ando, Y

ANNALS OF ONCOLOGY 28 巻 2017年9月

A phase 1 study of BYL719, an a-isoform selective PI3K inhibitor, in Japanese patients with advanced solid malignancies

Tomomatsu, J; Iwasa, S; Saka, H; Takahashi, S; Nakano, K; Morita, S; Inoue, M; Nakahama, H; Kogure, Y; Kakizume, T; Natsume, K; Aoki, T; Quadt, C; Yamada, Y; Ando, Y

ANNALS OF ONCOLOGY 28 巻 2017年9月

Erratum: High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review.

Yamamoto E, Niimi K, Fujikake K, Nishida T, Murata M, Mitsuma A, Ando Y, Kikkawa F

Molecular and clinical oncology 7 巻 ( 3 ) 頁： 510 2017年9月

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Kojima, H; Ishiyama, A; Hayashi, N; Takano, N; Hattori, N; Kobayashi, D; Tanaka, C; Hayashi, M; Kanda, M; Yamada, S; Sugimoto, H; Koike, M; Fujiwara, M; Fujii, T; Murotani, K; Ando, Y; Kodera, Y

BMC CANCER 17 巻 ( 1 ) 頁： 243 2017年4月

Adjuvant sunitinib for high-risk-resected renal cell carcinoma: a meta-analysis of ASSURE and S-TRAC trials

Gyawali, B; Ando, Y

ANNALS OF ONCOLOGY 28 巻 ( 4 ) 頁： 898 - 899 2017年4月

　前のページ - 次のページ　

<安藤 雄一>

論文 - 安藤 雄一

<安藤　雄一>

論文 - 安藤　雄一